Group 1: Company Developments - The company has completed the research and development of orthopedic CT series equipment, currently in the testing and clinical phase, and plans to launch it after obtaining regulatory production licenses [2] - A strategic cooperation agreement has been signed with the Hefei Institute of Physical Science, aiming to enter the high-end precision radiotherapy industry, particularly proton therapy [3] - The company has undertaken a national major scientific instrument project, developing an infrared mass spectrometry device for early liver cancer detection [3] Group 2: Shareholder Actions - Company executives completed a stock purchase plan on November 16, 2015, with a total investment exceeding 10 million yuan, reflecting confidence in the company's future [3] - Since its listing, the shareholding of directors, supervisors, and senior management has remained stable without significant fluctuations [3] Group 3: Market Outlook - The industrial testing market includes various sectors such as ordinary industrial product testing, food safety, environmental testing, and security checks, with significant future demand expected due to increased safety regulations [4] - The company aims for sales revenue from the industrial testing sector to reach 30% of total revenue in the future [4] Group 4: Financial Strategy - The company plans to increase investments in high-end medical imaging and industrial testing, considering mergers or restructuring to enhance competitiveness and profitability [4]
美亚光电(002690) - 2015年11月18日投资者关系活动记录表